Search

Your search keyword '"William Greenhalf"' showing total 335 results

Search Constraints

Start Over You searched for: Author "William Greenhalf" Remove constraint Author: "William Greenhalf"
335 results on '"William Greenhalf"'

Search Results

1. Long Covid: a global health issue – a prospective, cohort study set in four continents

2. 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study

3. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

4. Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways

5. Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation

6. Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning

7. Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial

8. United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer

9. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity

10. The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements

11. The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer

12. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

13. Concordance of human equilibrative nucleoside transporter‐1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial

14. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

15. Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes

16. Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk

17. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

18. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

19. Natural history of SPINK1 germline mutation related-pancreatitis

20. Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol

21. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.

22. Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.

23. Somatic mutations in exocrine pancreatic tumors: association with patient survival.

24. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue.

25. Pancreatic cancer susceptibility loci and their role in survival.

27. GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma

28. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

29. Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)

32. Supplementary Tables 1-5 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors

36. Supplementary Figure 3 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

37. Supplementary Figure S3. from Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus

38. Supplementary figures 1-4 from Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

39. Supplementary Table S2. from Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus

40. Supplementary Table 3 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

41. Supplementary Figure 6 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

42. Supplementary Table 4 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

43. Supplementary Figure 4 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

44. Data from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

45. Supplementary Figure Legends from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

46. Supplementary Figure 5 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

47. Supplementary Table 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

48. Supplementary Table 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

49. Supplementary Figure 2 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

50. Data from Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

Catalog

Books, media, physical & digital resources